Clinical Trial Update: Metformin Plus Modified FOLFOX 6 in Metastatic Pancreatic Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial assessing metformin plus modified FOLFOX 6 in metastatic pancreatic cancer has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• metformin + modified FOLFOX 6 (metformin, modified FOLFOX 6)

Snippet

Sponsor: Case Comprehensive Cancer Center | Conditions: Acinar Cell Adenocarcinoma of the Pancreas, Duct Cell Adenocarcinoma of the Pancreas | Phase 2 | Status: COMPLETED | Results posted: 2021-08-10